-
E7046
- names:
E7046
- CAS号:
1369489-71-3
MDL Number: - MF(分子式): C22H18F5N3O4 MW(分子量): 483.39
- EINECS: Reaxys Number:
- Pubchem ID: Brand:BIOFOUNT
| 货品编码 | 规格 | 纯度 | 价格 (¥) | 现价(¥) | 特价(¥) | 库存描述 | 数量 | 总计 (¥) |
|---|---|---|---|---|---|---|---|---|
| YZM004213-10mg | 10mg | 99.6% | ¥ 1755.00 | ¥ 1755.00 | 2-3天 | ¥ 0.00 | ||
| YZM004213-5mg | 5mg | 99.6% | ¥ 650.00 | ¥ 650.00 | 2-3天 | ¥ 0.00 |
| 中文别名 | |
| 英文别名 | |
| CAS号 | 1369489-71-3 |
| Inchi | |
| InchiKey | |
| 分子式 Formula | C22H18F5N3O4 |
| 分子量 Molecular Weight | 483.39 |
| 溶解度Solubility | 生物体外In Vitro:DMSO溶解度≥ 100 mg/mL(206.87 mM)*"≥" means soluble可溶, but saturation unknown溶解度未知. |
| 性状 | |
| 储藏条件 Storage conditions | 粉末Powder: -20°C 3 years年 4°C 2 years年 / In solvent溶液中:-80°C 6 months月 -20°C 1 month月 |
E7046(CAS:1369489-71-3)实验注意事项:
1.实验前需戴好防护眼镜,穿戴防护服和口罩,佩戴手套,避免与皮肤接触。
2.实验过程中如遇到有毒或者刺激性物质及有害物质产生,必要时实验操作需要手套箱内完成以免对实验人员造成伤害
3.实验后产生的废弃物需分类存储,并交于专业生物废气物处理公司处理,以免造成环境污染Experimental considerations:
1. Wear protective glasses, protective clothing and masks, gloves, and avoid contact with the skin during the experiment.
2. The waste generated after the experiment needs to be stored separately, and handed over to a professional biological waste gas treatment company to avoid environmental pollution.
1.实验前需戴好防护眼镜,穿戴防护服和口罩,佩戴手套,避免与皮肤接触。
2.实验过程中如遇到有毒或者刺激性物质及有害物质产生,必要时实验操作需要手套箱内完成以免对实验人员造成伤害
3.实验后产生的废弃物需分类存储,并交于专业生物废气物处理公司处理,以免造成环境污染Experimental considerations:
1. Wear protective glasses, protective clothing and masks, gloves, and avoid contact with the skin during the experiment.
2. The waste generated after the experiment needs to be stored separately, and handed over to a professional biological waste gas treatment company to avoid environmental pollution.
| 产品说明 | E7046 是一种有效的可口服的,特异性的EP4拮抗剂,IC50值为 13.5 nM, Ki值为 23.14 nM;E7046 具有抗肿瘤活性 |
| Introduction | E7046 is an orally bioavailable and specificEP4antagonist, withIC50of 13.5 nM and Kiof 23.14 nM, exhibiting antiumor activities. |
| Application1 | |
| Application2 | |
| Application3 |
E7046 是一种有效的可口服的,特异性的EP4拮抗剂,IC50值为 13.5 nM, Ki值为 23.14 nM;E7046 具有抗肿瘤活性。E7046 is an orally bioavailable and specificEP4antagonist, withIC50of 13.5 nM and Kiof 23.14 nM, exhibiting anti-tumor activities.
【1】.X. Bao, et al. Combination of a Novel EP4 Antagonist E7046 and Radiation Therapy Promotes Anti-tumor Immune Response and Tumor Rejection in Preclinical Tumor Models. International Journal of Radiation Oncology Biology Physics
【2】.Diana I. Albu, et al. EP4 Antagonism by E7046 diminishes Myeloid immunosuppression and synergizes with Treg-reducing IL-2-Diphtheria toxin fusion protein in restoring anti-tumor immunity. OncoImmunology.
【2】.Diana I. Albu, et al. EP4 Antagonism by E7046 diminishes Myeloid immunosuppression and synergizes with Treg-reducing IL-2-Diphtheria toxin fusion protein in restoring anti-tumor immunity. OncoImmunology.
对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
- 相关产品
-
< >
- 推荐产品
-
< >
- 最新产品
-
< >
新闻
抱歉,暂无数据!


购物车 


